Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Long-Term Deferred Tax (2017 - 2026)

Bioceres Crop Solutions' Long-Term Deferred Tax history spans 10 years, with the latest figure at $6.5 million for Q1 2026.

  • On a quarterly basis, Long-Term Deferred Tax changed N/A to $6.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $6.5 million, a N/A change, with the full-year FY2025 number at $4.9 million, down 49.48% from a year prior.
  • Long-Term Deferred Tax hit $6.5 million in Q1 2026 for Bioceres Crop Solutions, up from $4.9 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for BIOX hit a ceiling of $9.7 million in Q2 2024 and a floor of $654260.0 in Q2 2022.
  • Historically, Long-Term Deferred Tax has averaged $5.2 million across 5 years, with a median of $4.9 million in 2025.
  • Biggest five-year swings in Long-Term Deferred Tax: crashed 80.04% in 2022 and later surged 543.54% in 2023.
  • Tracing BIOX's Long-Term Deferred Tax over 5 years: stood at $654260.0 in 2022, then surged by 543.54% to $4.2 million in 2023, then surged by 130.35% to $9.7 million in 2024, then crashed by 49.48% to $4.9 million in 2025, then skyrocketed by 32.65% to $6.5 million in 2026.
  • Business Quant data shows Long-Term Deferred Tax for BIOX at $6.5 million in Q1 2026, $4.9 million in Q2 2025, and $9.7 million in Q2 2024.